GCM
RMD icon

Gunderson Capital Management’s ResMed RMD Stock Holding History

Gunderson Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-23,666
Closed -$4.54M – 57
2020
Q2 		$4.54M Buy
+23,666
New +$3.87M 3.66% 13

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gunderson Capital Management's RMD Position: Q3 2020 in Review

Gunderson Capital Management sold out of ResMed (RMD) in Q3 2020, closing a stake of 23,666 shares — an estimated $4.54M sold.

Gunderson Capital Management first reported a position in RMD in Q2 2020 and held it in 1 quarter. The position peaked at $4.54M in Q2 2020. 627 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

  • Gunderson Capital Management reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
  • Gunderson Capital Management sold 23,666 ResMed shares in Q3 2020, an estimated $4.54M.
  • Gunderson Capital Management first reported a position in ResMed in Q2 2020 and held it in 1 quarter.
  • Gunderson Capital Management's ResMed position peaked at $4.54M in Q2 2020.
  • 627 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Gunderson Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.